April 8, 2019 Intelligence: Late Breaking Lab News

By Robert Michel | From the Volume XXVI No. 5 – April 8, 2019 Issue

BeaconLBS announced a collaboration with MagnaCare of Garden City, N.Y., last month. The press release issued by the two companies stated that MagnaCare would use the “BeaconLBS Physician Decision Support (PDS) solution with its network of physician and laboratory…

Read More

---

February 25, 2019 Intelligence: Late Breaking Lab News

By Robert Michel | From the Volume XXVI No. 3 – February 25, 2019 Issue

Quest Diagnostics sold its clinical laboratory business in India last December, thus ending a 12-year effort to build a thriving business in that nation of 1.3 billion people. The buyer was Strand Life Sciences of Bengaluru, India. The transaction was announced in a…

Read More

---

Judge Rules ‘Pull-Through’ Is Illegal Inducement

By Joseph Burns | From the Volume XXV No. 14 – October 1, 2018 Issue

CEO SUMMARY: In a ruling issued Sept. 12, a U.S. District Court judge decided that two common clinical laboratory business practices are illegal inducements that can lead to charges of ling false claims. The practices occur when labs pay physicians to package and mail patients’ specimen…

Read More

---

Is the Joint Venture Hospital Lab an Emerging Trend?

By R. Lewis Dark | From the Volume XXV No. 12 – August 20, 2018 Issue

CEO SUMMARY: THE DARK REPORT has uncovered a previously unnoticed trend that turns common wisdom on Wall Street upside down: Hospitals and health systems may be taking back control of their their …

Read More

---

ProMedica, Sonic Form Lab Outreach Joint Venture

By Joseph Burns | From the Volume XXV No. 12 – August 20, 2018 Issue

CEO SUMMARY: Fast-growing ProMedica Health System of Toledo, Ohio, agreed to a laboratory joint venture with Sonic Healthcare USA. As lab budgets and prices for lab tests are squeezed downward, ProMedica sees opportunity to add volume to this new core lab facility to improve efficiency an…

Read More

---

Do Hospitals Want to Sell or Outsource Their Labs?

By Robert Michel | From the Volume XXV No. 12 – August 20, 2018 Issue

This is an excerpt from a 883-word article in the August 20, 2018 issue of THE DARK REPORT. The complete article and two related articles are available to all readers, with a three-article cap. CEO SUMMARY: Common wisdom on Wall Street is that many hospi…

Read More

---

CMS physician fee schedule: Will hospital labs be excluded again from PAMA price reporting?

By R. Lewis Dark | From the Volume XXV No. 11 – July 30, 2018 Issue

CEO SUMMARY: Publication of the draft CMS Physician Fee Schedule on July 12 brought unwelcome news for the clinical lab industry, at least as it pertains to that perennial question: Should hospital lab outreach data be included in a PAMA market study? The federal Centers for Medicare and …

Read More

---

CMS Shows Its Hand in New Draft Rules for 2019

By Joseph Burns | From the Volume XXV No. 11 – July 30, 2018 Issue

CEO SUMMARY: Publication of the draft Medicare Physician Fee Schedule on July 12 brought unwelcome news for the clinical lab industry, at least as it pertains to whether hospital lab outreach data should be included in the PAMA market study that the federal Centers for Medicare and Medica…

Read More

---

In HDL Case, Judge Imposes Damages, Penalties of $114 Million

By Joseph Burns | From the Volume XXV No. 8 – May 29, 2018 Issue

LAST WEEK, A FEDERAL JUDGE in South Carolina issued an order imposing civil damages and penalties of more than $114 million on Tonya Mallory, the former CEO of Health Diagnostic Laboratory, in Richmond, Va., and two owners of the lab’s marketing partner, BlueWave Healthcare…

Read More

---

Use of ‘1099 Marketers’ and Lab Compliance Risk

By Jon Stone | From the Volume XXV No. 3 – February 12, 2018 Issue

CEO SUMMARY: Experts in lab compliance predict that clinical laboratories and anatomic pathology groups must anticipate tougher enforcement of federal and state laws this year. One source of increased compliance risk for lab companies is the rising use of third-party marketing agreements….

Read More

---